Looking forward ...MoreI've heard alot of good things about this product so I'm excited to try it
This commitment to clean, science-backed formulas is what allows our community to make confident decisions about their wellness
10.3390/nu12092832 50
First, phase II clinical trials evaluating MOTS-c in type 2 diabetes and sarcopenia are in development, and their results will provide the first randomized controlled evidence in humans to define therapeutic doses with statistical rigor
Avoid applying to broken, irritated, or extremely sensitive skin
Santos JX, Rasga C, Marques AR, Martiniano H, Asif M, Vilela J, Oliveira G, Sousa L, Nunes A, Vicente AM (2022) A role for gene-environment interactions in autism spectrum disorder is supported by variants in genes regulating the effects of exposure to xenobiotics